Raymond Schondelmeyer
Internal Medicine · Columbia, MONPI 1801895032
Payments from drug & device makers
Across 481 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- Lilly USA, LLC$828
- Novo Nordisk$743
- AstraZeneca$658
- AbbVie$441
- Amarin Pharma, Inc.$433
- plus $3K from 26 others
What the payments were for
- Food & beverage$7,55799%
- Education$881%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 82 | $1,472 |
| Lilly USA, LLC | 54 | $828 |
| Novo Nordisk | 51 | $743 |
| AstraZeneca | 33 | $658 |
| AbbVie(2 entities) | 28 | $441 |
| Amarin Pharma, Inc. | 26 | $433 |
| GSK | 32 | $403 |
| Abbott | 35 | $379 |
| Astellas Pharma US Inc | 12 | $306 |
| Merck | 20 | $286 |
| Pfizer | 16 | $257 |
| Eisai Inc. | 8 | $196 |
| Novartis | 12 | $189 |
| Boehringer Ingelheim | 10 | $167 |
| Sunovion Pharmaceuticals Inc. | 10 | $137 |
| E.r. Squibb & Sons, L.L.C. | 9 | $126 |
| Kowa Pharmaceuticals America, Inc. | 9 | $119 |
| Esperion Therapeutics, Inc. | 6 | $90 |
| Bayer | 5 | $89 |
| Radius Health, Inc. | 6 | $84 |
| Nestle Healthcare Nutrition Inc. | 2 | $34 |
| Biohaven Pharmaceuticals, Inc. | 2 | $29 |
| Johnson & Johnson | 2 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $26 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Nevro Corp. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $14 |
| Tandem Diabetes Care, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Ironwood Pharmaceuticals, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,645 in reported general payments places this provider in the 90th percentile of 2,097 internal medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CombiganBrimonidine Tartrate/Timolol | 12 | $2,556 |
| Famotidine | 22 | $118 |
| Amlodipine Besylate | 22 | $71 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCombigan | $441 | $2,55612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,097 internal medicine providers in Missouri.
Other internal medicine in Columbia
- Dima DandachiColumbia$1.2M
- Puja NistalaColumbia$235K
- Syed NaqviColumbia$139K
- Donald DelwoodColumbia$84K
- Timothy SmithSaint Peters$21.4M
- Craig DietzKansas City$4M
- Michael ReschakSaint Louis$3.1M
- Santosh SharmaKansas City$782K
- Jianbo WangChesterfield$643K
- David PrelutskySaint Louis$575K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.